Director/PDMR Shareholding

Dechra Pharmaceuticals PLC
19 September 2006




           Dechra Pharmaceuticals PLC - Directors / PDMR Sharedealing
                         Long Term Incentive Plan 2003


Dechra Pharmaceuticals PLC announces that as a result of the achievement of the
targets of the LTIP 2003 Scheme, Directors and PDMR's have today exercised
options to subscribe for ordinary shares in the Company and then sold as
follows:

Name             Capacity   Options           Exercise Price     Shares Sold   Sale Price
                            Exercised         (per exercise)
                  
                                     
Ian Page         Director   120,000                £1            49,348        £2.50

Simon Evans      Director    80,000                £1            0

Edwin Torr       Director    80,000                £1            32,898        £2.50

Giles Coley      PDMR        50,000                £1            20,562        £2.50
                                                               
Michael Annice   PDMR        50,000                £1            20,562        £2.50




                      This information is provided by RNS
            The company news service from the London Stock Exchange